Inoviq Ltd has released a press release.
Commercial and R&D Update
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Inoviq
- Healthcare Conference Investor Presentation
- IIQ Appendix 4C & Quarterly Activities Report-September 2022
- Canadian Patent Granted for BARD1 Technology
- Receipt of R&D Tax Incentive Refund
- INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform
Later from Inoviq
- INOVIQ Settles Legal Proceedings
- CEO AGM Presentation
- MST Access Diagnostics Forum Presentation
- Positive EXO-NET Results in Ovarian Cancer
- Appendix 4C & Quarterly Activities Report - December 2022
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq